Showing results (931-940 of 1,041) with videos related to

Sort By:
Pageof 105
Virchows Archiv : an International Journal of Pathology|November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinomaEun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Nature Genetics|September 21, 2010
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Ellen L Goode, Georgia Chenevix-Trench, Honglin Song, et al.
Research Square|February 24, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.
Human Mutation|February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
International Journal of Epidemiology|September 6, 2016
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization studyJue-Sheng Ong, Gabriel Cuellar-Partida, Yi Lu, et al.
Nature Genetics|September 21, 2010
Common variants at 19p13 are associated with susceptibility to ovarian cancerKelly L Bolton, Jonathan Tyrer, Honglin Song, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association ConsortiumMia M Gaudet, Roger L Milne, Angela Cox, et al.
Communications Biology|January 19, 2022
Rare germline copy number variants (CNVs) and breast cancer riskJoe Dennis, Jonathan P Tyrer, Logan C Walker, et al.
Cancer Medicine|July 4, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.
British Journal of Cancer|March 21, 2018
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation studySuzanne C Dixon-Suen, Christina M Nagle, Aaron P Thrift, et al.
Pageof 105